SCHEMBL31444008

SCHEMBL31444008

Cn1nc(I)c2ccc(Br)c(OCc3ccccc3)c21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PKM P14618 3/20 0.43
▸ SMN1; SMN2 Q16637 3/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ MAOB P27338 2/20 0.36
▸ MAPK14 Q16539 1/20 0.36
▸ MAOA P21397 1/20 0.36
▸ THRB P10828 2/20 0.36
▸ THRA P10827 1/20 0.36
▸ MEN1 O00255 4/20 0.35
▸ KMT2A Q03164 4/20 0.35
▸ ALDH1A1 P00352 3/20 0.35
▸ HTT P42858 2/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ HPGD P15428 2/20 0.35
▸ GAA P10253 3/20 0.35
▸ POLB P06746 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ BRD4 O60885 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31575020 0.78 NQO2 (0.34) L3MBTL1
SCHEMBL31444183 0.76 PKM (0.41) PKML3MBTL1CNR1ACHECNR2
SCHEMBL31443961 0.74 MAPK14 (0.40) PKMSMN1; SMN2L3MBTL1MAOBMAPK14
SCHEMBL31574990 0.70 PKM (0.40) PKMSMN1; SMN2L3MBTL1ALDH1A1HTT
SCHEMBL31575008 0.70 LMNA (0.33) L3MBTL1THRBLMNA
SCHEMBL13923710 0.68 MAOB (0.53) PKMSMN1; SMN2NPC1RAB9AL3MBTL1
SCHEMBL26635947 0.68 LMNA (0.30) L3MBTL1THRBLMNA
SCHEMBL30706223 0.68 LMNA (0.37) NPC1RAB9AL3MBTL1THRBMEN1
SCHEMBL26637934 0.68 LMNA (0.37) NPC1RAB9AL3MBTL1THRBMEN1
SCHEMBL25079226 0.68 ADORA3 (0.40) PKMNPC1RAB9AL3MBTL1MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025096856-A1 COVALENT CEREBLON LIGANDS C4 THERAPEUTICS, INC. (US) 2025-05-08 — — WO disclosed
Send feedback